Li, Fei <br/><br/>
Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity.  [electronic resource] 

 -  Nature communications  2013 
 - 2384 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>2041-1723 
<br/><br/><label>Standard No.: </label>10.1038/ncomms3384  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amidohydrolases--antagonists & inhibitors<br/>Animals<br/>Anti-Obesity Agents--pharmacology<br/>Antioxidants--pharmacology<br/>Bacterial Proteins--antagonists & inhibitors<br/>Cyclic N-Oxides--pharmacology<br/>Diet, High-Fat--adverse effects<br/>Gene Expression Regulation<br/>Glucose--metabolism<br/>Intestinal Absorption--drug effects<br/>Intestinal Mucosa--metabolism<br/>Intestines--drug effects<br/>Lactobacillus--drug effects<br/>Lipid Metabolism--drug effects<br/>Male<br/>Mice<br/>Mice, Knockout<br/>Microbiota--drug effects<br/>Obesity--drug therapy<br/>Receptors, Cytoplasmic and Nuclear--antagonists & inhibitors<br/>Signal Transduction<br/>Spin Labels<br/>Taurocholic Acid--agonists